Loading chat...
GA HB1081
Bill
Status
Introduced
1/30/2024
Primary Sponsor
Darlene Taylor
Click for details
AI Summary
- Establishes the "Georgia Preeclampsia Biomarker Testing Act of 2024," allowing pregnant women to be screened for preeclampsia using biomarker testing when ordered by their attending physician during prenatal care
- Requires biomarker tests to be conducted using FDA-approved methods and in accordance with nationally recognized clinical practice guidelines and consensus statements
- Mandates all health benefit policies renewed or issued on or after July 1, 2024, to include coverage for preeclampsia biomarker testing
- Requires Medicaid to provide preeclampsia biomarker testing coverage for eligible pregnant recipients
- Authorizes the Georgia Department of Public Health to promulgate rules and regulations for administering the testing requirements
Legislative Description
Health; provide mandatory preeclampsia biomarker testing for pregnant women during their first prenatal visit
Last Action
House Committee Favorably Reported By Substitute
2/16/2024
Committee Referrals
Public Health1/31/2024
Full Bill Text
No bill text available